Cite
HARVARD Citation
Mgodi, N. et al. (2021). A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings. Journal of acquired immune deficiency syndromes. pp. 680-687. [Online].